PeptiDream Profit Margin

The latest profit margin for PPTDF is -18.89% as of June 2026. That compares with -3.92% in the prior-year period — down 381.6% year over year. That is below the Healthcare sector average of 9.71%. Investors often review this figure alongside PeptiDream's historical trend and sector peers before judging valuation or financial health.

Over the past year, PPTDF's profit margin moved from -3.92% to -18.89% — a 381.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in PeptiDream's valuation or profitability profile.

Against Healthcare companies, PPTDF currently prints -18.89% for profit margin, while the sector average sits near 9.71%. That is roughly 294.6% below the sector mean. Large gaps often invite a closer look at PeptiDream's growth, margins, and balance sheet.

Profit Margin shows how effectively PeptiDream converts resources into returns. At -18.89%, PPTDF may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -3.92% in the prior-year period — down 381.6% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting PPTDF's profit margin (-18.89%), review year-over-year change from -3.92%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.